LncRNA Information | ||||||
---|---|---|---|---|---|---|
ID | EL0210 | Name | ATP6V1G2-DDX39B | Aliases | N/A | |
Species | Homo sapiens | Chromosome | 6 | Start site | 31530219 | |
End site | 31546608 | Chain | minus | Exon NO. | 13 | |
Assembly | Ensembl Release 89 | Class | N/A | NCBI accession | NR_037853 | |
Ensembl | ENSG00000254870 | Sequence |
Disease | |||||||||
---|---|---|---|---|---|---|---|---|---|
Disease | Method | Sample | Expression pattern | Dysfunction type | Description | PMID | Source | ||
dilated cardiomyopathy | N/A | N/A | N/A | mutation | The haplotype block, NFKBIL1-ATP6V1G2-BAT1-MICB-MICA, within the class III-class I boundary region of the human major histocompatibility complex may control susceptibility to hepatitis C virus-associated dilated cardiomyopathy. | 16101831 | LncRNADisease | ||
hepatitis C virus-associated dilated cardiomyopathy | N/A | N/A | N/A | mutation | The haplotype block, NFKBIL1-ATP6V1G2-BAT1-MICB-MICA, within the class III-class I boundary region of the human major histocompatibility complex may control susceptibility to hepatitis C virus-associated dilated cardiomyopathy. | 16101831 | LncRNADisease | ||